IL1RL1 and airway hyperresponsiveness: IL-33 and suppression of tumorigenicity 2 (ST2)/IL1RL1 (IL-33 receptor) play a role in allergen-induced eosinophil inflammation, mucus epithelial chemotaxis, and airway hyperresponsiveness and promote Th2 polarization to participate in the immune response[12].